SBP solbec pharmaceuticals limited

The interview says it all , phase1/2a trials two thirds complete...

  1. skint
    5,996 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    16/08/04
    10:14
    Post #: 547550
    The interview says it all , phase1/2a trials two thirds complete on cancer , POSITIVE REACTION AGAINST THE CANCERS ALREADY SEEN AT TINY DOSAGES , way earlier than they expected , no bad side effects ever seen , psoraisis trials , no partnership deals to be considered till some solid data to maximise returns to shareholders etc , etc .
    http://www.wallstreetreporter.com/linked/SolbecPharmaceuticals.html
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
NEWS Veteran executive to help turn Trigg into leading US-based antimony producer
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.